Product How it works Pricing Blog FAQ About Contact
Elevance Health

Elevance Health (NYSE: ELV) net income

Elevance Health reported a net profit of $5,662m for fiscal 2025, 5.3% less than in fiscal 2024 ($5,980m). Its net margin was 2.8%. Earnings per share were $25.28.

Net income, in millions of US dollars2,47020163,84320173,75020184,80720194,57220206,15820215,89420225,98720235,98020245,6622025

Net income by fiscal year

Fiscal yearNet incomeChangeNet marginEarnings per share
2025$5,662m−5.3%2.8%$25.28
2024$5,980m−0.1%3.4%$25.81
2023$5,987m+1.6%3.5%$25.38
2022$5,894m−4.3%3.8%$25.10
2021$6,158m+34.7%4.4%$25.04
2020$4,572m−4.9%—$18.23
2019$4,807m+28.2%4.6%$18.81
2018$3,750m−2.4%4.1%$14.53
2017$3,843m+55.6%4.3%$14.70
2016$2,470m—2.9%$9.39

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Questions about the net income of Elevance Health

How much did Elevance Health earn in fiscal 2025?
Elevance Health reported a net profit of $5,662m for fiscal 2025. In fiscal 2024 it reported a net profit of $5,980m.
What are the earnings per share of Elevance Health?
They were $25.28 in fiscal 2025, compared with $25.81 in fiscal 2024.
What is the net margin of Elevance Health?
In fiscal 2025 its net profit was 2.8% of its revenue.
What was the most profitable year for Elevance Health?
Of its last 10 fiscal years, fiscal 2021, with $6,158m.
Where do the figures for Elevance Health come from?
From the annual report (Form 10-K) that Elevance Health files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Elevance Health files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Elevance Health: the Elevance Health page · annual accounts · revenue · dividends paid · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.